HOME > 研究業績詳細

研究業績詳細

野崎 大司(ノザキ タイジ)

研究テーマ 移植免疫 腫瘍
研究業績(論文) 1. Efficacy and Feasibility of Intensity-Modulated Radiation Therapy for Prostate Cancer in Renal Transplant Recipients.
Iizuka J, Hashimoto Y, Hashimoto Y, Kondo T, Takagi T, Nozaki T, Shimizu T, Akimoto T, Ishida H, Karasawa K, Tanabe K.
Transplant Proc. 2016 Apr;48(3):914-7. doi: 10.1016/j.transproceed.2016.01.032.

2. Efficacy and Feasibility of Low-Dose Rate Brachytherapy for Prostate Cancer in Renal Transplant Recipients.
Iizuka J, Hashimoto Y, Hashimoto Y, Kondo T, Takagi T, Nozaki T, Shimizu T, Akimoto T, Ishida H, Karasawa K, Tanabe K.
Transplant Proc. 2016 Apr;48(3):910-3. doi: 10.1016/j.transproceed.2016.01.031

3. Robot-Assisted Radical Prostatectomy for Localized Prostate Cancer in Asian Renal Transplant Recipients.
Iizuka J, Hashimoto Y, Kondo T, Takagi T, Inui M, Nozaki T, Omoto K, Shimizu T, Ishida H, Tanabe K.
Transplant Proc. 2016 Apr;48(3):905-9. doi: 10.1016/j.transproceed.2016.01.036.

4. ABO-Incompatible Living Kidney Transplants: Evolution of Outcomes and Immunosuppressive Management.
Okumi M, Toki D, Nozaki T, Shimizu T, Shirakawa H, Omoto K, Inui M, Ishida H, Tanabe K.
Am J Transplant. 2016 Mar;16(3):886-96. doi: 10.1111/ajt.13502. Epub 2015 Nov 10.

5. Shimizu T, Toma H, Shibahara R, Tsunoyama K, Izuka J, Nozaki T, Ishida H, Tanabe K, Honda K, Koike J. Clinical and pathological analyses of chronic vascular rejection after kidney transplantation. Nephrology (Carlton). 2015 Jul;20 Suppl 2:20-5. doi: 10.1111/nep.12464.

6. Omae K, Kondo T, Takagi T, Morita S, Hashimoto Y, Kobayashi H, Iizuka J, Nozaki T, Yoshida K, Tanabe K. Renal sinus exposure as an independent factor predicting asymptomatic unruptured pseudoaneurysm formation detected in the early postoperative period after minimally invasive partial nephrectomy. Int J Urol. 2015 Apr;22(4):356-61. doi: 10.1111/iju.12696. Epub 2015 Jan 12.

7. Ishida H, Kondo T, Shimizu T, Nozaki T, Tanabe K. Postoperative rebound of antiblood type antibodies and antibody-mediated rejection after ABO-incompatible living-related kidney transplantation. Transpl Int. 2015 Mar;28(3):286-96. doi: 10.1111/tri.12482.

8. Ishii D, Rosenblum JM, Nozaki T, Schenk AD, Setoguchi K, Su CA, Gorbacheva V, Baldwin WM 3rd, Valujskikh A, Fairchild RL. Novel CD8 T Cell Alloreactivities in CCR5-Deficient Recipients of Class II MHC Disparate Kidney Grafts. J Immunol. 2014 Aug 29. pii: 1303256. [Epub ahead of print]

9. Omoto K, Nozaki T, Inui M, Hirai T, Sawada Y, Shimizu T, Toki D, Ishida H, Tanabe K. Retroperitoneoscopic Donor Nephrectomy With Multiple Renal Arteries Does Not Affect Graft Survival and Ureteral Complications. Transplantation. 2014 Jul 22. [Epub ahead of print]

10. Shimizu T, Ishida H, Toki D, Nozaki T, Omoto K, Tanabe K, Honda K, Koike J.
Clinical and pathological analyses of transplant glomerulopathy cases. Nephrology (Carlton). 2014 Jun;19 Suppl 3:21-6. doi: 10.1111/nep.12243.

11. Ishida H, Furusawa M, Shimizu T, Nozaki T, Tanabe K. Influence of preoperative anti-HLA antibodies on short- and long-term graft survival in recipients with or without rituximab treatment. Transpl Int. 2014 Apr;27(4):371-82.

12. Kondo T, Takagi T, Kobayashi H, Iizuka J, Nozaki T, Hashimoto Y, Ikezawa E, Yoshida K, Omae K, Tanabe K. Superior tolerability of altered dosing schedule of sunitinib with 2-weeks-on and 1-week-off in patients with metastatic renal cell carcinoma--comparison to standard dosing schedule of 4-weeks-on and 2-weeks-off. Jpn J Clin Oncol. 2014 Mar;44(3):270-7.

13. Omoto K, Nozaki T, Inui M, Shimizu T, Hirai T, Sawada Y, Ishida H, Tanabe K. Impact of right-sided nephrectomy on long-term outcomes in retroperitoneoscopic live donor nephrectomy at single center. J Transplant. 2013;2013:546373.

14. Ryosaka M, Omoto K, Nozaki T, Yoshida K, Sawada Y, Hirano H, Shimizu T, Ishida H, Tanabe K. Successful Kidney Transplantation for End-Stage Renal Disease in Marfan's Syndrome. Case Rep Transplant. 2013;2013:809613.



研究者 教育活動